Peregrine Pharmaceuticals (PPHM)
Peregrine Pharmaceuticals Market Cap: 47.76M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PPHM Market Cap Rankings
| Overall | 14th percentile | 4001 of 4664 |
| Sector | 19th percentile | 426 of 527 in Healthcare |
| Industry | 18th percentile | 134 of 164 in Biotechnology |
PPHM Market Cap Range, Past 5 Years
| Minimum | 30.35M | Oct 2009 |
| Maximum | 206.31M | Apr 2010 |
| Average | 112.74M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these PPHM related companies
PPHM News
@BSB $PPHM Phase 2 results are good, stock still punished but good phase 3 results and nda filings will turn this ship around!
about 3 days ago by BiopharmaPro
about 3 days ago by BiopharmaPro
RT @HighGrowthFinancial after seeing $PPHM bounce today, $KVA is gettting some attention, downside shrinking
about 6 days ago by HighGrowthFinancial
about 6 days ago by HighGrowthFinancial
$PPHM stock receives no love yet shows good results. I think people are skeptical on Bavixtbaum. but it could prove to be ideal for cancer
about 7 days ago by BiopharmaPro
about 7 days ago by BiopharmaPro
@BiopharmaPro $PPHM is getting some press from bloggers like Wall ST Cheat ..I just like the bowl formation. IMO it hits 0.80 at the MA200.
about 7 days ago by Urbane_Gorilla
about 7 days ago by Urbane_Gorilla
@Urbane_Gorilla $PPHM is an under the radar stock! Good phase 2 results thus far. Once more come out and shows Bavi works ... will run!!!
about 7 days ago by BiopharmaPro
about 7 days ago by BiopharmaPro
only small cap pharm in my crosshairs today i didn't pull trigger on $PPHM ...hate chasin, waitin for .55
about 7 days ago by HighGrowthFinancial
about 7 days ago by HighGrowthFinancial
$PPHM holding recent gains ok,called $KVA out off there strength few days ago,great companies now risky,Horrible companies working LONG
about 7 days ago by HighGrowthFinancial
about 7 days ago by HighGrowthFinancial
$PPHM Price fell in an instance and I believe the price can recover in an instance
about 9 days ago by FinantricALew
about 9 days ago by FinantricALew
$PPHM Looking for continuation. Phase III clinicals are in development. Promising company. http://stks.co/3vsq
about 9 days ago by FinantricALew
about 9 days ago by FinantricALew
after seeing $PPHM bounce today, $KVA is gettting some attention, downside shrinking
about 10 days ago by HighGrowthFinancial
about 10 days ago by HighGrowthFinancial
@HighGrowthFinancial $PPHM You know the stocks that you buy? The one's that are hated by everyone else! Zooooom!!!
about 10 days ago by BiopharmaPro
about 10 days ago by BiopharmaPro
Penn Virginia Corporation, Peregrine Pharmaceuticals Among Stocks Gapping Up Monday
May 21, 10:31AM Fox Business
May 21, 10:31AM Fox Business
@danielmardorf $PPHM considering how bad the market was this thing held up nuetral! you should bow down to it!
about 13 days ago by BiopharmaPro
about 13 days ago by BiopharmaPro
RT @HighRiskBuyer $PPHM out out out and out. Never buy this when it's already up. It's a money trap. Out and off my watch list forever! true
about 31 days ago by Dragonballz
about 31 days ago by Dragonballz
$PPHM out out out and out. Never buy this when it's already up. It's a money trap. Out and off my watch list forever!
about 31 days ago by HighRiskBuyer
about 31 days ago by HighRiskBuyer
@Winwin123 $ARNA $KERX both go up today I'll celebrate by buying some $PPHM just for kicks!
about 31 days ago by BiopharmaPro
about 31 days ago by BiopharmaPro
@gofigure $PPHM $NGSX $GALE short term yes, but Long term no they are not done! All have huge potential for big gains!
about 32 days ago by BiopharmaPro
about 32 days ago by BiopharmaPro
$pphm bid/ask/close and after hours all at .40 flat. Sharp turn coming, please let it be north for a change.
about 36 days ago by HighRiskBuyer
about 36 days ago by HighRiskBuyer
AVID Bioservices Highlights Antibody Engineering, Expression and Bioassay Expertise at AACR
Apr 02, 4:00PM Marketwire
Apr 02, 4:00PM Marketwire
Roth Capital removed Peregrine Pharmaceuticals (PPHM) from its Focus List
Mar 12, 8:53AM Street Insider
Mar 12, 8:53AM Street Insider
Peregrine Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Mar 09, 10:00PM Seeking Alpha
Mar 09, 10:00PM Seeking Alpha
Peregrine (PPHM) Reports Flat PFS, ORR Results in Bavituximab + Carboplatin Phase II
Mar 09, 8:13AM Street Insider
Mar 09, 8:13AM Street Insider
Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012
Mar 01, 4:00PM Marketwire
Mar 01, 4:00PM Marketwire
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
Mar 01, 8:00AM Marketwire
Mar 01, 8:00AM Marketwire
Peregrine Announces Participation at Upcoming Investor Conferences in March
Feb 27, 4:00PM Marketwire
Feb 27, 4:00PM Marketwire
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
Feb 23, 4:00PM Marketwire
Feb 23, 4:00PM Marketwire
Peregrine to Present at BIO CEO and Investor Conference on Tuesday, February 14, 2012 at 8:30 AM EST
Feb 09, 4:00PM Marketwire
Feb 09, 4:00PM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PPHM | 0.5503 | +0.00 | +0.05% | 47.73M |
| PPH | 36.88 | -0.04 | -0.11% | |
| PPG | 103.39 | +1.13 | +1.11% | 15.60B |
| PPC | 8.21 | +0.13 | +1.61% | 1.733B |
| PPBI | 7.85 | -0.06 | -0.76% | 81.17M |
| PPA | 18.50 | -0.06 | -0.32% | |
| POZN | 6.91 | -0.11 | -1.57% | 210.46M |
| POWR | 4.14 | -0.16 | -3.72% | 81.31M |
| POWL | 36.78 | +0.01 | +0.03% | 432.05M |
| POWI | 40.76 | +0.13 | +0.32% | 1.149B |